BTL Aesthetics
BTL is a global medical technology company that develops and manufactures advanced medical devices across aesthetics, rehabilitation, mental health, cardiology, hospital-based therapies, and veterinary medicine.
Last updated September 15, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
BTL is a global medical technology company with over 30 years of experience in developing and manufacturing advanced medical devices. It operates across multiple segments, including aesthetics, rehabilitation, mental health, cardiology, hospital-based therapies, and veterinary medicine, and its portfolio includes specialized technologies such as robotic systems for selected therapeutic applications. BTL develops and manufactures its core technologies in-house, with a focus on engineering, clinical validation, and real-world usability, and operates in more than 80 countries with 80+ offices worldwide and 500+ researchers and engineers. Its technologies are used daily in hospitals, clinics, and specialized practices worldwide, and it partners with multiple medical specialties including primary care, joints and spine, pain management, dental, dermatology and med spas, ophthalmology, GLP-1 and weight loss, and intimate health providers.
History
BTL is a global medical technology company with over 30 years of experience in developing and manufacturing advanced medical devices. It develops and manufactures its core technologies in-house, with a strong focus on engineering, clinical validation, and real-world usability. Today, BTL operates in more than 80 countries, supported by a global team of researchers, engineers, and clinical specialists, and its technologies are used daily in hospitals, clinics, and specialized practices worldwide.
Controversies
2021
BTL settlement over EMSCULPT trademark use
BTL Industries reached a settlement with Pinky Promise Beauty after alleging unauthorized use of the EMSCULPT trademark to advertise treatments using a counterfeit device. Under a court-entered consent judgment, Pinky Promise agreed to stop using BTL trademarks and copyrighted images in its marketing, pay damages, and forfeit the device.
2021
BTL and AbbVie settle patent dispute
BTL announced that it had resolved its patent infringement claims against AbbVie related to BTL's muscle stimulation technology. Under the settlement, AbbVie will pay BTL an undisclosed amount, and pending litigation between the parties will be dismissed.
Recent events
BTL settlement over EMSCULPT trademark use[3]
Reported:
BTL Industries reached a settlement with Pinky Promise Beauty after alleging unauthorized use of the EMSCULPT trademark to advertise treatments using a counterfeit device. Under a court-entered consent judgment, Pinky Promise agreed to stop using BTL trademarks and copyrighted images in its marketing, pay damages, and forfeit the device.
BTL and AbbVie settle patent dispute[4]
Reported:
BTL announced that it had resolved its patent infringement claims against AbbVie related to BTL's muscle stimulation technology. Under the settlement, AbbVie will pay BTL an undisclosed amount, and pending litigation between the parties will be dismissed.
BTL Aesthetics products win multiple industry awards[5]
Reported:
BTL Aesthetics announced that Emsculpt Classic, Emsculpt NEO, and Emsella had been named winners in several aesthetic publication awards.
Sources5 sources
Cite this profile: Cite the canonical profile. /brand-wiki/btl-aesthetics · Editorial policy · How profiles are compiled